Analyst Ratings for Nuvation Bio Inc (NUVB)
NUVB Rating Summary
NUVB Price Target Summary
- Highest: $21.00 (H.C. Wainwright)
- Lowest: $7.00 (UBS)
- Average: $13.11
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.11 (+97.5%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
Avg. $ Target:
$13.11 (+97.5%)
* Over Last 12-Mos
Rating Score: 8.7 / 10
Percentile Rank: 87%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | Cantor Fitzgerald | Li Watsek | New Coverage | Overweight (N/A) |
N/A (N/A) |
6.83 (6.64) |
-2.78% | Details |
| 8/18/2026 | JPMorgan | Priyanka Grover | New Coverage | Overweight (N/A) |
13.00 (N/A) |
6.22 (6.64) |
6.75% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
